System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+924 today

System

Livenow

Terminal Asset View

stockNASDAQ

URGN

$18.44-1.86%

UroGen Pharma Ltd

Neutral

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

21Neutral

Live Analysis Active

Company Mission

UroGen Pharma creates specialized liquid medicines that treat rare cancers in the urinary tract system. Doctors use these treatments for patients with specific bladder and kidney cancers where traditional surgery isn't ideal. The company makes money by selling these prescription drugs to hospitals, clinics, and pharmacies.

URG

Industry Context

The biotechnology industry focuses on developing medical treatments using biological systems. Small biotech companies like UroGen often experience significant price swings based on clinical trial results, regulatory approvals, and investor sentiment toward healthcare innovation.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

60Matrix

Market Momentum

39.3— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.8x— Normal Volume

Today's Change

-1.86%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing URGN across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 07:37 AM UTC

As-of 03-15-2026 07:22 UTC

Develops prescription drugs that treat urinary tract cancers and makes money by selling these medicines to hospitals and clinics.

Price remains below key moving averages, suggesting a downtrend as sellers maintain control over recent weeks showing consolidation pattern.

Biotech sector faces volatility with regulatory uncertainty, watch for industry sentiment shifts affecting small-cap drug developers, suggesting.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...